大剂量1-β-D-阿拉伯呋喃糖基胞嘧啶治疗难治性白血病期间白血病母细胞中1-β-D-阿拉伯呋喃糖基胞嘧啶5'-三磷酸的细胞药理学及最佳治疗浓度 - Suppr | 超能文献

Cellular pharmacology and optimal therapeutic concentrations of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in leukemic blasts during treatment of refractory leukemia with high-dose 1-beta-D-arabinofuranosylcytosine.

作者信息

Plunkett W, Iacoboni S, Keating M J

出版信息

Scand J Haematol Suppl. 1986;44:51-9. doi: 10.1111/j.1600-0609.1986.tb01590.x.

DOI:10.1111/j.1600-0609.1986.tb01590.x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Cellular pharmacology and optimal therapeutic concentrations of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in leukemic blasts during treatment of refractory leukemia with high-dose 1-beta-D-arabinofuranosylcytosine.大剂量1-β-D-阿拉伯呋喃糖基胞嘧啶治疗难治性白血病期间白血病母细胞中1-β-D-阿拉伯呋喃糖基胞嘧啶5'-三磷酸的细胞药理学及最佳治疗浓度

Scand J Haematol Suppl. 1986;44:51-9. doi: 10.1111/j.1600-0609.1986.tb01590.x.

2

Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy.高剂量1-β-D-阿拉伯呋喃糖基胞嘧啶治疗期间白血病细胞中1-β-D-阿拉伯呋喃糖基胞嘧啶5'-三磷酸积累的饱和度

Cancer Res. 1987 Jun 1;47(11):3005-11.

3

Correlation between leukemic cell retention of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and response to therapy.1-β-D-阿拉伯呋喃糖基胞嘧啶5'-三磷酸在白血病细胞中的潴留与治疗反应之间的相关性。

Cancer Res. 1979 Jan;39(1):42-9.

4

Quantitation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-beta-D-arabinofuranosylcytosine therapy.接受1-β-D-阿拉伯呋喃糖基胞嘧啶治疗的患者骨髓和外周血白血病细胞中1-β-D-阿拉伯呋喃糖基胞嘧啶5'-三磷酸的定量分析。

Cancer Res. 1980 Mar;40(3):588-91.

5

Pharmacokinetics of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in leukemic cells after intravenous and subcutaneous administration of 1-beta-D-arabinofuranosylcytosine.静脉注射和皮下注射1-β-D-阿拉伯呋喃糖基胞嘧啶后白血病细胞中1-β-D-阿拉伯呋喃糖基胞嘧啶5'-三磷酸的药代动力学

Cancer Res. 1985 May;45(5):2373-5.

6

Pharmacologically directed design of leukemia therapy.白血病治疗的药理学导向设计。

Haematol Blood Transfus. 1990;33:610-3. doi: 10.1007/978-3-642-74643-7_111.

7

Degradation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human leukemic myeloblasts and lymphoblasts.

Cancer Res. 1987 Jun 15;47(12):3130-5.

8

Effect of m-AMSA on the cellular pharmacology of ara-CTP in human leukemic cells during therapy with high-dose ara-C.在大剂量阿糖胞苷治疗期间，甲氧基柔红霉素对阿糖胞苷三磷酸在人白血病细胞中的细胞药理学作用。

Adv Exp Med Biol. 1986;195 Pt B:171-5. doi: 10.1007/978-1-4684-1248-2_26.

9

Simultaneous determination of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and 3-deazauridine 5'-triphosphate in human leukemia cells by high-performance liquid chromatography.高效液相色谱法同时测定人白血病细胞中1-β-D-阿拉伯呋喃糖基胞嘧啶5'-三磷酸酯和3-去氮尿苷5'-三磷酸酯

J Chromatogr. 1980 Dec 12;221(2):425-30. doi: 10.1016/s0378-4347(00)84334-0.

10

Efficient formation of cytosine arabinoside-5'-triphosphate in leukemic blasts of human T-cell acute lymphoblastic leukemia.人T细胞急性淋巴细胞白血病白血病母细胞中阿糖胞苷-5'-三磷酸的高效形成。

Leuk Res. 1989;13(10):931-6. doi: 10.1016/0145-2126(89)90047-7.

引用本文的文献

1

Oral cytarabine ocfosfate pharmacokinetics and assessment of leukocyte biomarkers in normal dogs.正常犬口服阿糖胞苷磷酸酯的药代动力学和白细胞生物标志物评估。

J Vet Intern Med. 2023 Nov-Dec;37(6):2429-2442. doi: 10.1111/jvim.16842. Epub 2023 Sep 5.

2

Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies.利用 Vpx 蛋白靶向 SAMHD1 以改善血液系统恶性肿瘤的阿糖胞苷治疗。

Nat Med. 2017 Feb;23(2):256-263. doi: 10.1038/nm.4265. Epub 2017 Jan 9.

3

Metabolism, mechanism of action and sensitivity profile of fluorocyclopentenylcytosine (RX-3117; TV-1360).氟环戊烯基胞嘧啶（RX-3117；TV-1360）的代谢、作用机制和敏感性特征。

Invest New Drugs. 2013 Dec;31(6):1444-57. doi: 10.1007/s10637-013-0025-x. Epub 2013 Sep 19.